| Literature DB >> 6507515 |
M A Rettenmaier, R D Miller, M L Berman, P J DiSaia.
Abstract
Moxalactam was administered prior to operation to patients undergoing operation for a known or suspected gynecologic malignancy. Subsequent plasma and tissue levels demonstrated a prolonged duration of action and rapid concentration in pelvic organs after infusion.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6507515 DOI： 10.1016/0002-9378(84)90467-8
Source DB: PubMed Journal: Am J Obstet Gynecol ISSN： 0002-9378 Impact factor: 8.661